Phase 2Enrolling by invitationAge-related condition

The Progressive Supranuclear Palsy Clinical Trial Platform - Regimen B: LM11A-31

Sponsor
Adam Boxer (Academic or other)
Enrollment
147 planned
Conditions
PSP - Progressive Supranuclear Palsy
Interventions
LM11A-31; Matching Placebo
Ages
adults, older adults
Registry
NCT07264283

Full record on ClinicalTrials.gov

From the registry

The Progressive Supranuclear Palsy Clinical Trial Platform (PTP) is a multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of PSP. Regimen B will evaluate the safety and efficacy of a single study drug, LM11A-31, in participants with PSP.

Primary outcomes

  • Disease progression

History

  1. Primary completion expected

  2. Last registry update

  3. Started

  4. Registered